License Agreement with Duke - Additional Information (Detail) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Mar. 03, 2023 |
Nov. 30, 2023 |
May 31, 2026 |
Nov. 30, 2021 |
|
| Patent Option And Technology License Agreement [Line Items] | ||||
| Impairment of assets | $ 13,108,064 | |||
| Duke University [Member] | ||||
| Patent Option And Technology License Agreement [Line Items] | ||||
| Amount on excess damages | $ 100,000,000 | |||
| Milestone payments first phase III clinical trial | $ 2,000,000 | |||
| Capitalized costs to obtain agreement | $ 15,372,382 | |||
| Capitalized costs amortization period | 16 years | |||
| Duke license agreement, termination date | May 17, 2025 | |||
| Research Agreement [Member] | ||||
| Patent Option And Technology License Agreement [Line Items] | ||||
| Consideration payable for research | $ 187,400 |